Stanford University
Showing 261-280 of 1,649 Results
-
Ekanath Srihari Rangan
Affiliate, Department Funds
Resident in MedicineCurrent Research and Scholarly InterestsWearable medical systems for non-invasive and pervasive health monitoring in cardiovascular and critical care contexts; Correlation of genomic aspects of disease with phenotypic data from electronic health records; Informatics and machine learning for precise detection and early warning of infectious diseases; Preemptive protocols for managing disease severity trajectories; And IoT based Telemedicine.
-
Alok Ranjan
Physical Science Research Scientist
BioAccomplished Research Scientist with a rich history (6-8 years) of spearheading cutting-edge research projects. Proficient in synthesizing and analyzing new compounds with therapeutic potential. Experienced in utilizing both structure and property-based strategies to identify promising drug candidates. Led multidisciplinary teams to innovate solutions, enhanced drug discovery efficiency by integrating advanced computational techniques. Committed to continuous learning and staying well-informed of the latest trends in medicinal chemistry and drug design.
-
Julia D. Ransohoff
Instructor, Medicine - Oncology
BioDr. Ransohoff received her B.A. from Harvard College in Human Developmental and Regenerative Biology and completed her medical training at Stanford University, where she received her M.D., completed residency in internal medicine, and fellowship training in hematology and oncology as part of the American Board of Internal Medicine Physician Scientist Training Program.
Dr. Ransohoff is a physician-scientist dedicated to improving breast cancer treatments and outcomes through developing genomic methods to profile how tumors respond to treatment. Her research focuses on molecular approaches to understand the variable clinical responses of breast cancers to treatment at the genomic level by profiling molecular residual disease. Her current work involves exploring mechanisms of chemoresistance and immune evasion and identifying novel therapeutic targets. In related work, she also studies epidemiological risk factors for breast cancer mortality with a focus on the gut microbiome, oncofertility, and racial and ethnic differences in treatment response. Dr. Ransohoff's research has been supported by the ASCO Conquer Cancer Foundation, the Terri Brodeur Breast Cancer Foundation, the Stanford Cancer Institute, ECOG-ACRIN, and the Chan Zuckerberg Initiative.
As an Instructor in the Division of Medical Oncology, Dr. Ransohoff is also a clinically active oncologist, treating patients with breast cancer. -
Adithi Rao
Life Science Rsch Prof 2, Biology
Current Role at StanfordResearch Professional at the Laboratory of Organismal Biology, Gilbert Hall
